MedPath

Effect of acupressure on fatigue and anxiety in the patients with cancer

Phase 2
Conditions
Condition 1: Anxiety. Condition 2: Cancer. Condition 3: Cancer. Condition 4: Cancer. Condition 5: Cancer. Condition 6: Cancer. Condition 7: Fatigue. Condition 8: Cancer.
Other mixed anxiety disorders
Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue
Malignant neoplasms of ill-defined, secondary and unspecified sites
Malignant neoplasms of independent (primary) multiple sites
In situ neoplasms
Neoplasms of uncertain or unknown behaviour
Malaise and fatigue
Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
C00, C01,
Registration Number
IRCT201301219759N2
Lead Sponsor
Vice-Chancellor of Research and Technology, Hamadan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
90
Inclusion Criteria

The patients with cancer in hematology unit will be included in the study with following criteria: (a) II, III, and IV stages of cancer; (b) consciousness; (c) lack of amputation or ulcer at the acupoints; (d) lack of sever heart failure; (e) lack of hypothyroidism; (f) lack of coagulant disorders. The patients will be excluded from the study with the following criteria: (a) hemoglobin less than nine gram per deciliter; (b) platelet less than 50000 per microliter; (c) pregnancy.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fatigue. Timepoint: Before intervention, before the sixth session of intervention and after the tenth session of intervention. Method of measurement: Brief Fatigue Inventory questionnaire.;Anxiety. Timepoint: Before intervention, before the sixth session of intervention and after the tenth session of intervention. Method of measurement: Spielberger anxiety questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath